Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...

Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

Knee osteoarthritis treatments are challenging due to pain and joint structure variability. Lorecivivint (LOR) is an ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss ...

Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a ...

For individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and ...

Cymbalta (duloxetine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) that can be used as a second-line treatment for knee OA. In addition to regulating mood, this antidepressant has been ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee osteoarthritis-related pain in people with obesity, a trial finds.

Do you suffer from knee pain during or after movement? Does knee pain limit your mobility or prevent you from enjoying some activities you previously found joy in? There is mounting evidence that ...